Assessment of Children With Tic Onset in the Past 6 Months
NewTics
Predictive Biomarkers of Conversion to Tourette Syndrome in Children With New-Onset Tics
2 other identifiers
observational
99
1 country
1
Brief Summary
The purpose of this research is to study why most children who have tics never develop Tourette syndrome but some do. In other words, we aim to find features that may predict whose tics will go away and whose tics will continue or worsen, in children ages 5 through 10 years whose first tic occurred within the past 9 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 5, 2010
CompletedFirst Posted
Study publicly available on registry
August 9, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 13, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 13, 2023
CompletedNovember 27, 2023
November 1, 2023
13 years
August 5, 2010
November 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
DSM-5 diagnosis of a chronic tic disorder at 12 months
Research diagnosis of a chronic tic disorder at 12 months (cases), versus those whose tics are absent at 12 months (controls), will define two groups who will be compared on their baseline status (almost a year earlier) on a quantitative measure of functional connectivity maturity, pre-tic BOLD signal, caudate nucleus volume, and several clinical and neuropsychological measures.
1 year after the onset of tics (6-12 months after the first study visit)
Study Arms (4)
Recent-onset tics that will persist
Children between 5 to 10 years of age with recent-onset tics (first tic occurred within the past 9 months) who, when reassessed at 1 year after the first tic began (i.e. 6-12 months after study enrollment) will turn out to meet criteria for a chronic tic disorder (including Tourette syndrome). Scheduled follow-up visits will include children over age 10 (initially enrolled at age 5-10).
Recent-onset tics that will remit
Children between 5 to 10 years of age with recent-onset tics (first tic occurred within the past 9 months) who will no longer have tics when reassessed 1 year after the first tic began (6 to 12 months after study enrollment). Scheduled follow-up visits will include children over age 10 (initially enrolled at age 5-10).
Tic-free control subjects
Children with no current or past tic disorder of similar age, sex and handedness as the children in the recent-onset tics groups.
Existing TS/CTD
Children with current tics whose first tics were more than 12 months ago (DSM-5 Tourette's Disorder or Persistent \[Chronic\] Motor or Phonic Tic Disorder), of similar age, sex and handedness as the children in the recent-onset tics groups.
Eligibility Criteria
1. A convenience sample of children age 5-10 who have tics now but whose first-ever tic occurred within the past 9 months. Subjects will be a convenience sample from community and clinical sources. 2. A control group who already meets criteria for a diagnosis of a chronic tic disorder, matched for age, sex, handedness, and ADHD 3. A control group who has no tics, matched for age, sex, handedness, and ADHD
You may qualify if:
- Age 5-10
- Informed consent from a parent and assent from the child.
- New Tics Group \*\*
- tics now, but developed them only in the past 9 months.
You may not qualify if:
- \*\* Existing TS/CTD control group \*\*
- children who meet DSM-5 criteria for Tourette's Disorder or Persistent Tic Disorder at enrollment
- matched to children from the New Tics group on age (within 1 year), sex, handedness, and ADHD status.
- \*\* Tic-free controls \*\*
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Washington University School of Medicine, Movement Disorder Clinic
St Louis, Missouri, 63110, United States
Related Links
- Click here for more information about this study: Predictive Biomarkers of Conversion to Tourette Syndrome in Children with New-Onset Tics
- Click here for more information about this study: Predictive Biomarkers of Conversion to Tourette Syndrome in Children with New-Onset Tics
- Tourette Syndrome resources
Biospecimen
saliva
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kevin J. Black, MD
Washington University School of Medicine
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 5, 2010
First Posted
August 9, 2010
Study Start
August 1, 2010
Primary Completion
July 13, 2023
Study Completion
July 13, 2023
Last Updated
November 27, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Subject-level data: first data upload approximately 25 September 2018, then twice yearly through the end of the grant period.
- Access Criteria
- open
Beginning in June, 2017, all data other than PHI will follow the NIMH RDoC data sharing policy.